Accessibility Menu
Convatec Group Plc logo

Convatec Group Plc(LSE) CTEC

Current Price£2.16
Market Cap£4.21BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2016)+15%
5 Year-18%
1 Year-11%
1 Month+3%
Convatec Group Plc last closing stock price
MetricPriceDate
Last closeGBX 216.002026-07-24
Convatec Group Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.37%GBX 216.802026-07-17
1 month+3.15%GBX 209.402026-06-24
3 month-2.17%GBX 220.802026-04-24
Year to date-11.18%GBX 243.202025-12-31
1 year-11.18%GBX 243.202025-07-24
3 year+3.35%GBX 209.002023-07-25
5 year-17.71%GBX 262.502021-07-23
Since inception+15.27%GBX 1.842016-10-26

Convatec Group Plc Financials at a Glance

Market Cap

£4.21BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$4.73B

Net Income (TTM)

$365.84M

EPS (TTM)

£0.07

P/E Ratio

33.18

Dividend

£0.05

Beta (Volatility)

0.07 (Low)

Price

£2.16

Volume

4,059,229

Open

£2.12

Previous Close

£2.16

Daily Range

£2.12 - £2.17

52-Week Range

£1.93 - £2.59

Estimated Earnings Date

Aug 4, 2026

CTEC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Convatec Group Plc

ConvaTec Group Plc operates as a global medical technology company, specializing in the creation, production, and worldwide distribution of a diverse array of healthcare products. The company focuses on advanced wound care, ostomy care, and continence and critical care solutions, catering to various healthcare needs.

Products and Services
  • Advanced wound care products for managing acute and chronic wounds
  • Ostomy care devices and accessories for individuals with a stoma
  • Continence and critical care solutions, including urinary catheters
Growth Outlook
  • Revenue growth of 7.5% year-over-year in the latest quarter
  • Strong demand in advanced wound care and ostomy markets
  • Expansion into emerging markets expected to drive future growth
Financial Highlights
  • Latest quarterly revenue of $1.27 billion, up from $1.18 billion
  • Net income of $70.5 million, reflecting a net profit margin of 5.6%
  • Trailing twelve months (TTM) dividend yield of 2.5%
ConvaTec Group Plc has established itself as a key player in the medical technology sector, with a strong focus on innovation and quality. The company's diverse product portfolio addresses critical healthcare needs, positioning it well for future growth. Recent financial performance indicates a positive trajectory, with significant revenue increases and a solid net income. The ongoing expansion into emerging markets and the strong demand for its products suggest that ConvaTec is well-positioned to capitalize on future opportunities in the healthcare industry.
AI Generated • Jul 21, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

10,910

CEO

Jonathan Peter Mason, MBA

Website

www.convatec.com

Headquarters

London, GL RG1 3JH, GB

CTEC Financials

Key Financial Metrics (TTM)

Gross Margin

55.76%

Operating Margin

16.51%

Net Income Margin

7.17%

Return on Equity

10.53%

Return on Capital

13.68%

Return on Assets

4.64%

Earnings Yield

3.01%

Dividend Yield

2.49%

Payout Ratio

78.06%

Stock Overview

Market Cap

£4.21BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.95B

Volume

4.06M

Avg. Volume

7.90M

Financials (TTM)

Gross Profit

$2.65B

Operating Income

$728.47M

EBITDA

$1.16B

Operating Cash Flow

$862.20M

Capital Expenditure

-$242.85M

Free Cash Flow

$619.35M

Cash & ST Invst.

$75.03M

Total Debt

$1.52B

Convatec Group Plc Performance Analysis

Convatec Group Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,682,524,23113.5%
20232023-12-31USD 1,723,500,1212.4%
20242024-12-31USD 1,791,499,4093.9%
20252025-12-31USD 1,850,685,1993.3%
Convatec Group Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-302.4%
Q42024-12-315.6%
Q22025-06-300.3%
Q42025-12-317.2%
Convatec Group Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.03-40.8%
20232023-12-31USD 0.05104.4%
20242024-12-31USD 0.0741.9%
20252025-12-31USD 0.07-9.9%
Convatec Group Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-305.2%
Q42024-12-3142.9%
Q22025-06-30-6.6%
Q42025-12-31-31.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$1.27B

+16.4%

Gross Profit

$706.17M

+16.1%

Gross Margin

55.82%

N/A

Market Cap

£4.21BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£385.95K

N/A

Employees

10,910

N/A

Net Income

$70.54M

-5.4%

EBITDA

$338.22M

+43.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$75.03M

-23.7%

Total Debt

$1.52B

+15.7%

Accounts Receivable

$439.16M

+62.8%

Inventory

$416.15M

+5.1%

Long Term Debt

$1.49B

+15.5%

Short Term Debt

$26.00M

+24.4%

Return on Assets

4.64%

N/A

Return on Invested Capital

12.75%

N/A

Free Cash Flow

$246.85M

+16.0%

Operating Cash Flow

$311.00M

+9.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HIK.LHikma Pharmaceuticals PLC
£15.82+1.87%
HCM.LHUTCHMED (China) Limited
£1.66-3.63%
SPI.LSpire Healthcare Group plc
£2.24+1.36%
AMS.LAdvanced Medical Solutions Group plc
£2.80-0.18%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$92.32-0.08%
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
SOFISoFi Technologies
$16.46-0.01%

Questions About CTEC

What is the current price of Convatec Group Plc?

Convatec Group Plc is trading at £2.16 per share.

What is the 52-week range for Convatec Group Plc?

Over the past 52 weeks, Convatec Group Plc has traded between £1.93 and £2.59.

How much debt does Convatec Group Plc have?

As of the most recent reporting period, Convatec Group Plc reported total debt of $1.13B.

How much cash does Convatec Group Plc have on hand?

Convatec Group Plc reported $55.76M in cash and cash equivalents in its most recent financial results.

What is Convatec Group Plc’s dividend yield?

Convatec Group Plc currently has a dividend yield of 2.49%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services